Oligomeric tumer necrosis factor α slowly converts into inactive forms at bioactive levels (original) (raw)
The stability of oligomeric human tumour necrasis factor a (TNF) at bioactive levels has been studied by two immunoenzymatic assays: one able to specifically detect oligomeric and not monomeric TNF (O-e.l.i.s.a.) and the other able to detect both forms (OM-e.l.i.s.a.). The selectivity of O-e.l.i.s.a. and OM-e.l.i.s.a. for oligomeric and monomeric TNF was demonstrated with isolated forms prepared by partial dissociation of recombinant TNF with 10% (v/v) dimethyl sulphoxide and gel-filtration h.p.l.c. Evidence for instability of oligomeric TNF were obtained in physiological buffers, as well as in serum and cell-culture supernatants, as a function of TNF concentration. In particular, only a half of the TNF antigen was recovered in the oligomeric form after 72 h incubation (37°C) at 0.12 nm, whereas no apparent dissociation was detected at 4 nm. The structural changes observed at picomolar concentrations were rapidly reversed by raising the concentration of TNF to about 2 nm by ultrafiltration, suggesting that subunit dissociation and reassociation reactions occur in the picomolar and nanomolar range respectively. The cytolytic activity of L-M cells correlates with oligomeric-TNF levels after incubation at picomolar concentrations. Moreover, isolated oligomeric TNF was cytotoxic towards L-M cells, whereas monomeric TNF was virtually inactive. In conclusion, the results suggest that bioactive oligomeric TNF is unstable at picomolar levels and slowly converts into inactive monomers, supporting the hypothesis that quaternary-structure changes in TNF may contribute to the fine regulation of TNF cytotoxicity.
Sign up for access to the world's latest research.
checkGet notified about relevant papers
checkSave papers to use in your research
checkJoin the discussion with peers
checkTrack your impact
Related papers
Scandinavian Journal of Immunology, 1989
Recombinant human tumour necrosis factor (rTNF) retained ils cytotoxic activity after being fixed with para formaldehyde to adherent cell monolayers. The cytotoxicity appeared to be mainly due to fixeJ rTNF and not to any free soluble rTNF ihat couid have leaked out from the fixed rTNF eell preparations. The fixed rTNF eell preparations also stimulated the growth of human diploid fibroblasts. under eonditions where little growth-stimulatory aetivity was found in suspension. These resuUs indicate that TNF may exert its effect on target cells without inlernalization. perhaps through a receptor-media ted process tbat may alter the levels of a second messenger within the target cells. This signal transduction does not appear to involve cAMP or eGMP, since we were unable to detect significant changes in the levels of these two second messengers in TNF-exposed WEHI 164 elone 13 cells.
Tumor necrosis factor Characterization at the molecular, cellular and in vivo level
Febs Letters, 1991
TNF was originally characterized as an antitumor agent and a factor cytotoxic for many malignant cells. It is now clear that it plays an important role in the defense against viral, bacterial and parasitic infections, -and in (auto-)immune responses. Natural induction of TWF is protective, but its overproduction may he detrimental and even lethal to the host. The steucture of TNF and its interaction with the two types of cellular receptor are becoming better understood. TNF elicits a variety of events in different cell types. It subverts the electron transport system or the mitochondria into production of oxygen radicals, which can kill the (malignant) cells when these do not contain or produce protective enzymes. Furthermore, TNF induces a set of genes and at least part of this transcriptional activation is mediated by NFKB. The prospects of TNF as an antitumor drug can be improved on the one hand by agents such as LI+, which synergizes, and on the other hand by inhibitors of the systemic toxicity which do not interfere with the antitumor efficacy. Also, in tumor-bearing animals which have been rendered tolerant by administration of small doses of TNF, an effective and complete elimination of the tumors can be obtained by the combined action of TNF plus interferon.
The effects of tumor necrosis factor (TNF) derivatives on TNF receptors
Cytokine, 1993
The pleiotropic cytokine TNF has been implicated in the regulation of many immune and inflammatory responses in vivo, and in addition exerts a wide range of effects on target cells in vitro. However, although two cell surface receptors for TNF have been identified, and their cDNAs cloned, the amino acid residues necessary for the biological activity of TNF have not been characterized. We have therefore constructed derivatives of TNF termed 'muteins', in which the first 3 to 7 amino acids of native TNF-a have been replaced, using synthetic cDNA expressed in E. co/i. In the present study we compare the effects of native TNF-a and muteins III, IV, V and VI in several different in vitro systems and in one in vivo model. We observed binding to the ~75 TNF receptor on Jijoye Burkitt lymphoma cells with native TNF-cw and mutein III alone, whereas the ~55 TNF receptor on the human epithelioid carcinoma cell line HeLa bound TNF-a, mutein III and mutein V. Muteins IV and VI failed to recognize either TNF receptor. WEHI 164 fibrosarcoma cells were killed by muteins III, V and VI. Human umbilical vein endothelial cells responded to native TNF-(U and to muteins III, IV and V, but not to mutein VI, by increasing the surface expression of ICAM-antigen and secretion of the cytokines GM-CSF and IL-6. All four compounds were pro-inflammatory in a mouse in vivo model. The results presented in this report confirm that N-terminal amino acids are critical for both receptor binding and biological activity of TNF-cw. Amino acid substitution in the N-terminal region of the TNF-a molecule may provide an insight into the mechanism of TNF-a receptor binding, and further elucidate the structural requirements for its biological activity.
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors
Journal of Experimental Medicine, 1992
The receptors for tumor necrosis factor (TNF) exist in cell-associated as well as soluble forms, both binding specifically to TNF. Since the soluble forms of TNF receptors (sTNF-Rs) can compete with the cell-associated TNF receptors for TNF, it was suggested that they function as inhibitors of TNF activity; at high concentrations, the sTNF-Rs indeed inhibit TNF effects. However, we report here that in the presence of low concentrations of the sTNF-Rs, effects of TNF whose induction depend on prolonged treatment with this cytokine are augmented, reflecting an attenuation by the sTNF-Rs of spontaneous TNF activity decay. Evidence that this stabilization of TNF activity by the sTNF-Rs follows from stabilization of TNF structure within the complexes that TNF forms with the sTNF-Rs is presented here, suggesting that the sTNF-Rs can affect TNF activity not only by interfering with its binding to cells but also by stabilizing its structure and preserving its activity, thus augmenting some ...
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.